Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-10-21

Clinical Trial Update: Registry of Patients Treated With Systemic Mold-Active Triazoles

View source ↗

Summary

A completed registry of patients treated with systemic mold-active triazole antifungals for invasive fungal infections, summarizing real-world use of voriconazo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isavuconazole (Isavuconazole)
  • POSACONAZOLE (POSACONAZOLE)
  • VORICONAZOLE (Voriconazole)

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Invasive Fungal Infection | Status: COMPLETED